Cargando…
Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
Patients with fulminant type 1 diabetes almost completely lack C-peptide even soon after the onset of the disease, and the deficiency continues for the rest of their life. Thus, fulminant type 1 diabetes could serve as a good model of nature to explore the physiological role of C-peptide. For exampl...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323619/ https://www.ncbi.nlm.nih.gov/pubmed/18437231 http://dx.doi.org/10.1155/2008/819123 |
_version_ | 1782152671908593664 |
---|---|
author | Murase-Mishiba, Yuko Imagawa, A. Hanafusa, Toshiaki |
author_facet | Murase-Mishiba, Yuko Imagawa, A. Hanafusa, Toshiaki |
author_sort | Murase-Mishiba, Yuko |
collection | PubMed |
description | Patients with fulminant type 1 diabetes almost completely lack C-peptide even soon after the onset of the disease, and the deficiency continues for the rest of their life. Thus, fulminant type 1 diabetes could serve as a good model of nature to explore the physiological role of C-peptide. For example, patients with fulminant type 1 diabetes have diabetic chronic complications more frequently than those with classical autoimmune type 1 diabetes 5 years after the onset of diabetes, and the higher prevalence could be partly attributable to the complete lack of C-peptide in fulminant type 1 diabetes. |
format | Text |
id | pubmed-2323619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-23236192008-04-24 Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide Murase-Mishiba, Yuko Imagawa, A. Hanafusa, Toshiaki Exp Diabetes Res Review Article Patients with fulminant type 1 diabetes almost completely lack C-peptide even soon after the onset of the disease, and the deficiency continues for the rest of their life. Thus, fulminant type 1 diabetes could serve as a good model of nature to explore the physiological role of C-peptide. For example, patients with fulminant type 1 diabetes have diabetic chronic complications more frequently than those with classical autoimmune type 1 diabetes 5 years after the onset of diabetes, and the higher prevalence could be partly attributable to the complete lack of C-peptide in fulminant type 1 diabetes. Hindawi Publishing Corporation 2008 2008-04-15 /pmc/articles/PMC2323619/ /pubmed/18437231 http://dx.doi.org/10.1155/2008/819123 Text en Copyright © 2008 Yuko Murase-Mishiba et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Murase-Mishiba, Yuko Imagawa, A. Hanafusa, Toshiaki Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide |
title | Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide |
title_full | Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide |
title_fullStr | Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide |
title_full_unstemmed | Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide |
title_short | Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide |
title_sort | fulminant type 1 diabetes as a model of nature to explore the role of c-peptide |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323619/ https://www.ncbi.nlm.nih.gov/pubmed/18437231 http://dx.doi.org/10.1155/2008/819123 |
work_keys_str_mv | AT murasemishibayuko fulminanttype1diabetesasamodelofnaturetoexploretheroleofcpeptide AT imagawaa fulminanttype1diabetesasamodelofnaturetoexploretheroleofcpeptide AT hanafusatoshiaki fulminanttype1diabetesasamodelofnaturetoexploretheroleofcpeptide |